IRIS
Chiappini, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 339
EU - Europa 295
SA - Sud America 197
NA - Nord America 111
AF - Africa 13
OC - Oceania 1
Totale 956
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 232
BR - Brasile 179
SG - Singapore 175
US - Stati Uniti d'America 85
CN - Cina 37
HK - Hong Kong 30
FR - Francia 17
VN - Vietnam 16
MX - Messico 15
PK - Pakistan 14
PH - Filippine 12
BD - Bangladesh 11
AR - Argentina 10
DE - Germania 10
IN - India 10
CA - Canada 9
GB - Regno Unito 9
TR - Turchia 7
NL - Olanda 6
IQ - Iraq 5
JO - Giordania 5
GH - Ghana 4
VE - Venezuela 4
AL - Albania 3
ES - Italia 3
ID - Indonesia 3
MA - Marocco 3
NP - Nepal 3
PL - Polonia 3
RO - Romania 3
SA - Arabia Saudita 3
UA - Ucraina 3
FI - Finlandia 2
KE - Kenya 2
OM - Oman 2
RU - Federazione Russa 2
YE - Yemen 2
ZA - Sudafrica 2
AU - Australia 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
JM - Giamaica 1
KZ - Kazakistan 1
PY - Paraguay 1
TH - Thailandia 1
TN - Tunisia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 956
Salva come PNG Salva come JPEG
Città #
Rome 160
Singapore 116
Beijing 34
Hong Kong 27
Mexico City 14
Karachi 9
São Paulo 7
Ashburn 6
Milan 6
Perugia 6
Rio de Janeiro 6
Santa Clara 6
Aci Catena 5
Amman 5
Dhaka 5
Florence 5
Accra 4
Belo Horizonte 4
Benevento 4
Brasília 4
Frankfurt am Main 4
Ho Chi Minh City 4
Naples 4
Porto Alegre 4
Ankara 3
Bucharest 3
Cotia 3
Curitiba 3
Delhi 3
Fortaleza 3
Hanoi 3
Manila 3
Mumbai 3
Paranaque City 3
Sermoneta 3
Wroclaw 3
Amparo 2
Aracaju 2
Atlanta 2
Boydton 2
Caracas 2
Casablanca 2
Contagem 2
El Paso 2
Goiânia 2
Haiphong 2
Hamilton 2
Houston 2
Istanbul 2
Jeddah 2
Nairobi 2
Novara 2
Quezon City 2
Quận Bình Thạnh 2
Recife 2
Ribeirão Preto 2
Rio Tinto 2
Royal Tunbridge Wells 2
Salvador 2
San Juan 2
Sanaa 2
Seeb 2
São José dos Campos 2
Thái Nguyên 2
Tijucas 2
Tirana 2
Toronto 2
Vila Velha 2
Villa Raspa 2
Volta Redonda 2
Adapazarı 1
Addis Ababa 1
Adrogué 1
Alegrete do Piauí 1
Alexander 1
Alhambra 1
Almaty 1
Altos 1
Americana 1
Apucarana 1
Araçatuba 1
Arlington 1
Ars-sur-Moselle 1
Ashland City 1
Açu 1
Baltimore 1
Barra do Corda 1
Bathinda 1
Baton Rouge 1
Bel Air 1
Belvidere 1
Belém 1
Berlin 1
Bexley 1
Blackburn 1
Bocaiúva 1
Bologna 1
Bom Jesus da Lapa 1
Bothwell 1
Botucatu 1
Totale 583
Salva come PNG Salva come JPEG
Nome #
Understanding the use of prescription and OTC drugs in obtaining highs and the pharmacist role in preventing abuse 60
Le nuove sostanze psicoattive 36
'New/Designer Benzodiazepines': An Analysis of the Literature and Psychonauts' Trip Reports 25
Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study) 20
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): An Analysis of Pharmacovigilance Databases 19
Assessing The 2004-2018 Fentanyl Misusing Issues Reported To An International Range Of Adverse Reporting Systems 17
2876 – Glutamatergic strategies in the treatment of pathological gambling: a pilot study 15
Utilizzo del pregabalin nel trattamento del gioco d'azzardo patologico: dati preliminari 15
A multidisciplinary approach for addiction treatment in an Italian day hospital service: a therapy model and its goals 14
Gestione dei pazienti con depressione resistente al trattamento in comorbilità con il disturbo da uso di sostanze: sicurezza ed efficacia dell'esketamina in un sottocampione di pazienti dello studio REAL-ESK 14
A decade of gabapentinoid misuse: an analysis of the European Medicines Agency's ‘suspected adverse drug reactions' database. Assessment of gabapentinoid misuse/dependence as reported to the EMA 14
Beyond the purple drank. Study of promethazine abuse according to the Eurovigilance dataset 14
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data 14
Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review 13
Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel 13
A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases 13
Evaluation of an italian sample of gamblers with dannon ainhold gambling scale: preliminary study 12
The e-psychonaut drugs' psychopharmacology 12
Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset 12
Nuove frontiere nell'abuso di sostanze, psiconauti e internet 12
Psychobiological, medical, and psychiatric implications of new/novel psychoactive substance (NPS) use 12
Evaluating craving in Alcohol Use Disorder: psychometric characteristics of the Craving Typology Questionnaire-15 (CTQ-15) 12
Age in Pathological Gambling: Correlations with Personality and Psychiatric Comorbidity. 12
Pharmacovigilance signals of the opioid epidemic over 10 years: an analysis of pharmacovigilance datasets collecting Adverse Drug Reactions (ADRs) reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS) 11
New/emerging psychoactive substances and associated psychopathological consequences. 11
Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING) 11
Are finasteride-related penile curvature/Peyronie's disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases 11
Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study 11
The role of novel psychoactive substances (NPS) in mental health care of young people: a systematic review 11
Knowledge and use of over-the-counter drugs in Italy: an exploratory survey-based study in the general population 10
Addiction: a therapeutic model for the restructuring of identity 10
Brexpiprazole as a new approach of treatment in somatization disorder 10
Climate change, biodiversity loss and mental health: a global perspective 10
Behavioural changes in cocaine dependent patients after group-therapy 10
Fatalities Associated with Mephedrone in Combination with Other Stimulant Drugs in Young People Aged 16-24 Years 10
ARE Z-DRUGS SAFE? STUDY OF THEIR MISUSE, ABUSE AND DEPENDENCE ACCORDING TO THE EUROPEAN MEDICINES AGENCY (EMA) PHARMACOVIGILANCE DATABASE. 10
Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review 10
Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice 9
The bridge between classical and ‘synthetic'/chemical psychoses: towards a clinical, psychopathological and therapeutic perspective 9
High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults 9
Ibogaine/Noribogaine in the treatment of Substance Use Disorders: a systematic review and Meta-analysis of side effects 9
Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review 9
Cannabidiol (CBD) Use in Psychiatric Disorders: a Systematic Review 9
β-2 agonists as misusing Drugs? Assessment of both Clenbuterol- and Salbutamol-related European Medicines Agency (EMA) Pharmacovigilance Database Reports. 9
Beyond the ‘purple drank’. Study of promethazine abuse according to the European Medicines Agency (EMA) Adverse Drug Reactions (ADR) reports 9
Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group 9
Behavioural Addictions In Adolescence: Findings From An Italian Survey 9
Duration of untreated disorder and cannabis use: An observational study on a cohort of young italian patients experiencing psychotic experiences and dissociative symptoms 9
There is a potential of misuse for venlafaxine and bupropion? 9
Pregabalin treatment in pathological gambling: a preliminary study 9
Online Gambling, Impulsivity and Personality Traits: an Italian Sample 9
Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants 9
COVID-19: The hidden impact on mental health and drug addiction 9
Relationship between impulsivity, mood disorders and personality traits in a sample of pathological gamblers 9
Loperamide diversion and abuse: assessment of its non-medical use through the analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 9
Methoxetamine: An Analogue of Ketamine 8
Pregabalin: a range of misuse-related unanswered questions 8
Alprazolam-related deaths in Scotland, 2004-2020 8
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression 8
The Unregulated Psychoactive Compound: ‘Benzo Fury' 8
Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports 8
Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History 8
The benzydamine experience: a systematic review of benzydamine abuse 8
An Update on Psychoactive Substances: Pharmacology and Toxicology Issues 8
‘Z-trip'? A comprehensive overview and and a case-series of Zolpidem misuse 8
Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward 8
Substance-Use Disorders and Violence 8
Special M related fatalities in the UK. 7
An insight into Z-drugs abuse and dependence: an examination of reports to the European Medicines Agency (EMA) database of suspected Adverse Drug Reactions (ADR) 7
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review. 7
The misuse of prescription drugs in the digital era: pros and cons 7
NPS stimulants 7
Mobile phone use during adolescence: a new addiction? 7
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review 7
Efficacy of psychosocial and psychological interventions in addition to drug therapy to improve global functioning of inpatients with schizophrenia spectrum and mood disorders: a real-world observational study 7
The opioid epidemic over the past 10 years: pharmacovigilance signals from the European Medicines Agency (EMA) and the FDA Adverse Event Reporting System (FAERS) 7
Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction 7
Is there a potential of misuse for quetiapine? Literature review and analysis of the European Medicines Agency/EMA Adverse Drug Reactions' database 7
Psychopathologic aspects of obesity: Psychodiagnostic evaluations of bariatric surgery applicants 7
Validation of a diagnostic questionnaire based on DSM-IV criteria for gambling. 7
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 6
What about “pharming”? Issues regarding the misuse of prescription and over-the-counter drugs 6
New psychoactive substances (NPS), psychedelic experiences, and dissociation; clinical and clinical pharmacological issues. 6
Opioid painkiller dependence in a sample of elderly medical inpatients 6
Compulsiveness dimension in a case of pathological gambling 6
Psychosocial risk factors for postpartum depression: a descriptive sample of pregnants 6
Cannabis: evidenze epidemiologiche, cliniche e terapeutiche 5
Misuse of Anticholinergic Medications: A Systematic Review 5
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy 5
Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study 5
New psychoactive substances and suicidality: A systematic review of the current literature 5
To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality. 4
Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database 3
Misuse and Abuse of Prescription Drugs in Custodial Settings 3
Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports 3
Totale 969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20241 0 0 0 0 0 0 0 0 0 0 0 1
2024/2025787 21 102 3 0 22 12 61 129 56 40 191 150
2025/2026181 123 25 33 0 0 0 0 0 0 0 0 0
Totale 969